Enterprise Europe Network

German SME offers preclinical evaluation and dissolution test devices for special applications

Country of origin:
Country: 
GERMANY
Opportunity:
External Id: 
BODE20190304001
Published
05/03/2019
Last update
22/09/2020
Expiration date
21/03/2021

Keywords

Partner keyword: 
Diagnostics, Diagnosis
Medical Research
Laboratory equipment
Specialist medical practice activities
EXPRESS YOUR INTEREST

Summary

Summary: 
The company from the Northeast of Germany offers a broad spectrum of methods, products and expertise in the field of preclinical evaluation of solid oral dosage forms and oral drugs including biomolecules such as antibodies and enzymes. The company seeks for larger laboratories dealing with enzymatic assays and kits for determination of biological markers and selected proteins from human biological materials to collaborate in form of a service agreement.

Description

Description: 

The company was founded in 2009 as a spin-off of the University of Greifswald and focuses on innovative test equipment and methods to examine the release of pharmaceuticals.

The company has developed methods and products for preclinical evaluation and especially predictive pharmacopoeial dissolution testing under bio-relevant test conditions. The analytical services of the company include also further pharmacopoeial investigations of solid oral dosage forms and their mechanical stability as well as development and validation of analytical methods and procedures.
Biochemical characterisation of biomolecules are also on the market, e.g. characterization of proteins/peptides under denaturing and native conditions and determination of protein concentration.

The company looks for laboratories or industry partners dealing with enzymatic assays and kits for determination of biological markers and selected proteins from human biological materials. The partners would benefit from offered testing and evaluation under service agreement.

Advantages & innovations

Cooperation plus value: 
The German company is a highly innovative company focused on investigations of the dissolution behaviour of solid oral dosage forms under bio-relevant test conditions.The cutting edge test methods utilized by the company were established by the founders and are based on long experience in the fields of gastro-intestinal tract physiology and biopharmaceutical evaluation of dosage form performance. The bio-relevant test devices realistically simulate the mechanistic and physico-chemical conditions that act on dosage forms during their gastro-intestinal passage and enable the evaluation of their biopharmaceutical safety and reliability. The applicability of the test devices and test procedures was successfully validated on numerous examples of clinical relevance as well as in the routine analyses of solid oral dosage forms.

Technical Specification or Expertise Sought

Cooperation sought: 
Laboratories or industry partners dealing with enzymatic assays and kits for determination of biological markers and selected proteins from human biological materials

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
- interested laboratories or industry partners for service agreement - dealing with enzymatic assays and kits for determination of biological markers and selected proteins from human biological materials

Type and size

Cooperation task: 
SME 11-50,>500 MNE,>500